Cargando…

Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study

Pap test, and especially HPV DNA test, identify a large group of women who do not have any clinically relevant lesions, i.e., CIN2+ (Cervical Intraepithelial Neoplasia grade 2 or worse), but who are at greater risk of getting lesions in the future. The follow up of these women needs new biomarkers w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giorgi Rossi, Paolo, Benevolo, Maria, Vocaturo, Amina, Caraceni, Donatella, Ciccocioppo, Lucia, Frega, Antonio, Terrenato, Irene, Zappacosta, Roberta, French, Deborah, Rosini, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583834/ https://www.ncbi.nlm.nih.gov/pubmed/23460880 http://dx.doi.org/10.1371/journal.pone.0057600

Ejemplares similares

Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+)
por: Dorji, Namkha, et al.
Publicado: (2022)

Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
por: Liu, Ying, et al.
Publicado: (2023)

Analysis of New Colposcopy Techniques in the Diagnosis and Evolution of SIL/CIN: Comparison of Colposcopy with the DSI System (COLPO-DSI Study)
por: González González, Virginia, et al.
Publicado: (2023)

Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix
por: Benevolo, Maria, et al.
Publicado: (2012)

Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2+
por: Martí, Cristina, et al.
Publicado: (2021)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1
por: Souza, Carlos André Scheler de, et al.
Publicado: (2017)

Evaluation of adjunctive HPV testing by Hybrid Capture II(® )in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy
por: Guyot, Andrea, et al.
Publicado: (2003)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin-Fixed Paraffin-Embedded Cervical Specimens: Correlation with HPV-DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications
por: Zappacosta, Roberta, et al.
Publicado: (2013)

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
por: Ciavattini, Andrea, et al.
Publicado: (2020)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study
por: Zappacosta, Roberta, et al.
Publicado: (2017)

Rate of detecting CIN3+ among patients with ASC-US using digital colposcopy and dynamic spectral imaging
por: Harris, Karen Eloise, et al.
Publicado: (2020)

E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective
por: Origoni, Massimo, et al.
Publicado: (2015)

Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years
por: Paaso, Anna, et al.
Publicado: (2015)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway
por: French, Deborah, et al.
Publicado: (2013)

Evaluating HPV‐negative CIN2+ in the ATHENA trial
por: Petry, Karl Ulrich, et al.
Publicado: (2016)

Colposcopy telemedicine: live versus static swede score and accuracy in detecting CIN2+, a cross-sectional pilot study
por: Taghavi, Katayoun, et al.
Publicado: (2018)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy
por: Nasioutziki, Maria, et al.
Publicado: (2020)

A prospective randomized study on limits of colposcopy and histology: the skill of colposcopist and colposcopy-guided biopsy in diagnosis of cervical intraepithelial lesions
por: Bifulco, Giuseppe, et al.
Publicado: (2015)

Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy
por: Massad, L. Stewart, et al.
Publicado: (2023)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2018)

Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales
por: Pesola, F, et al.
Publicado: (2020)

Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
por: Beecroft, Marikka, et al.
Publicado: (2022)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023)

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
por: Giorgi Rossi, Paolo, et al.
Publicado: (2012)

MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy
por: Ye, Jing, et al.
Publicado: (2019)

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
por: Einstein, Mark H., et al.
Publicado: (2023)

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection
por: Monroy-García, Alberto, et al.
Publicado: (2011)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study
por: Young, Ailie, et al.
Publicado: (2018)

Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
por: León-Maldonado, Leith, et al.
Publicado: (2023)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6s1fo447e6433qc8guuf2n42nk